Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty

被引：0
|
作者：
Holmes, DR
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1997年 / 337卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1244 / 1245
页数：2
相关论文
共 50 条
  • [31] Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade - Comparison of transradial vs transfemoral arterial access
    Choussat, R
    Black, A
    Bossi, I
    Fajadet, J
    Marco, J
    EUROPEAN HEART JOURNAL, 2000, 21 (08) : 662 - 667
  • [32] Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab:: Importance of internal pool of glycoprotein IIb-IIIa receptors
    Gawaz, M
    Ruf, A
    Pogatsa-Murray, G
    Dickfeld, T
    Rüdiger, S
    Taubitz, W
    Fischer, J
    Müller, I
    Meier, D
    Patscheke, H
    Schömig, A
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) : 915 - 922
  • [33] Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab:: Importance of internal pool of glycoprotein IIb-IIIa receptors
    Gawaz, M
    Ruf, A
    Pogatsa-Murray, G
    Dickfeld, T
    Rüdiger, S
    Taugwitz, W
    Fischer, J
    Patscheke, H
    THROMBOSIS AND HAEMOSTASIS, 1999, : 725 - 726
  • [34] Platelet glycoprotein IIb/IIIa integrin blockade in coronary artery disease: Current state of the art
    Tan H.-C.
    Harrington R.A.
    Tcheng J.E.
    Journal of Thrombosis and Thrombolysis, 1997, 4 (3-4) : 431 - 439
  • [35] Is heparin still necessary after primary angioplasty in the era of platelet glycoprotein IIb/IIIa receptor inhibitors? A review of the literature
    Lettieri, Corrado
    De Servi, Stefano
    Buffoli, Francesca
    Aroldi, Marco
    Baccaglioni, Nicola
    Romano, Michele
    Tomasi, Luca
    Izzo, Antonio
    Zanini, Roberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (09) : 653 - 659
  • [36] Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
    Lincoff, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (8B): : 36P - 42P
  • [37] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14): : 956 - 961
  • [38] Differential benefit of glycoprotein IIb/IIIa receptor blockade in patients with optimal versus suboptimal angioplasty results
    Chao, JK
    Sabatine, MS
    Hahn, SS
    Deckelbaum, I
    King, SB
    Jung, IK
    CIRCULATION, 1999, 100 (18) : 187 - 188
  • [39] Unsticking platelets: the role of glycoprotein IIb/IIIa receptor blockade
    Armstrong, PW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 161 (11) : 1423 - 1424
  • [40] Adjunctive use of platelet glycoprotein IIb/IIIa blockade for high-risk carotid angioplasty and stent placement
    Suri, MFK
    Qureshi, AI
    Fessler, RD
    Ringer, AJ
    Khan, J
    Guterman, LR
    Hopkins, LN
    NEUROLOGY, 2000, 54 (07) : A63 - A63
12345